MxA mRNA quantification and disability progression in interferon beta-treated multiple sclerosis patients.

Even though anti-interferon beta (IFNβ) antibodies are the main determinants of IFNβ bioactivity loss and Myxovirus-resistance protein A (MxA) is the most established marker of IFNβ biological activity in IFNβ-treated multiple sclerosis patients, their usefulness in the routine clinical practice is...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Federico Serana, Luisa Imberti, Maria Pia Amato, Giancarlo Comi, Claudio Gasperini, Angelo Ghezzi, Vittorio Martinelli, Leandro Provinciali, Maria Rosa Rottoli, Stefano Sotgiu, Sergio Stecchi, Michele Vecchio, Mauro Zaffaroni, Cinzia Cordioli, Ruggero Capra
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Public Library of Science (PLoS) 2014-01-01
Цуврал:	PLoS ONE
Онлайн хандалт:	http://europepmc.org/articles/PMC3986392?pdf=render
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!